News

October 7, 2021

Hapbee Technologies, Inc.’s (OTCQB:HAPBF) (TSXV:HAPB) interview with Yona Shtern, CEO

Read More

October 7, 2021

EMulate Therapeutics Announces Positive Pre-Clinical Data in Mental Health Models and First in Human Experience Using its Proprietary Radio Frequency Energy Technology; Preliminary Results Emulate Drug Effects in Rodent Models and in Human Exposures

Read More

September 28, 2021

EMulate Therapeutics Announces Issuance of Additional U.S. Patent Covering a Therapeutic Device for Cancer and Other Health Indications

Read More

September 28, 2021

New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks

Read More

September 21, 2021

EMulate Therapeutics Announces Positive Pre-Clinical Data for its ulRFE(R) Technology Targeting Acute and Chronic Pain; Demonstrates Excellent Pain Reducing Effects Without the Use of Chemicals or Drugs

Read More

August 9, 2021

Hapbee Expands Leadership Team to Support Aggressive Growth Strategy

Read More

July 28, 2021

Hapbee Users Log Over 1 Million Hours of Use for Sleep, Focus and Alertness Signals

Read More

March 17, 2021

EMulate Therapeutics to Participate in the Venture Summit \ Virtual Connect West on March 17 at 12pm PST

Read More

March 17, 2021

EMulate Therapeutics: Ushering in a New Era in Non-Invasive Cancer Therapy

Read More

December 30, 2020

A Medical Technology That Has The Highest Potential Over Any We Follow

Read More

Older »